cefixime has been researched along with Chronic Bullous Disease of Childhood in 2 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sil, A | 1 |
Chandra, A | 1 |
Bhattacharjee, MS | 1 |
Biswas, SK | 1 |
Sarikaya Solak, S | 1 |
Ficicioglu, S | 1 |
1 review available for cefixime and Chronic Bullous Disease of Childhood
Article | Year |
---|---|
Cephalosporin-induced linear IgA dermatosis in a child: Case report and literature review.
Topics: Anti-Bacterial Agents; Cefixime; Child, Preschool; Drug Eruptions; Female; Humans; Linear IgA Bullou | 2019 |
1 other study available for cefixime and Chronic Bullous Disease of Childhood
Article | Year |
---|---|
Cefixime-induced linear IgA bullous dermatosis: a rare cause of mucocutaneous bullous eruption in a patient on hemodialysis.
Topics: Cefixime; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Renal Dialysis; Skin Diseases, Ve | 2022 |